Dr. John Richard Salzman, MD

Dr. Salzman practices at John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health.

Dr. Salzman's NPI, 1457349342, was assigned on October 13, 2005. Dr. Salzman graduated from Boston University School Of Medicine in 1970. Dr. Salzman holds California license G22265.

Dr. Salzman's primary practice is John Muir Medical Center, Walnut Creek, at 1601 Ygnacio Valley Rd, Walnut Creek, CA 94598 in Contra Costa County. The practice phone is (925) 939-3000.

Dr. Salzman's primary practice is John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health. Dr. Salzman is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. The medical group on file is John Muir Medical Group. Dmand AI also links Dr. Salzman to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salzman practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Salzman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Salzman is board certified in therapeutic radiology by the American Board of Radiology. Dr. Salzman is licensed in California.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Salzman treats.

CMS data shows 1,139 Medicare services from Dr. Salzman across 16 procedure codes in 2024, for 197 Medicare patients. Medicare paid $97,399 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 197 Medicare patients who saw Dr. Salzman in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have cancer, and 75% have high blood pressure. 49% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salzman's median patient age at 65, with 56% women.

In 2024, Dr. Salzman wrote 47 Medicare Part D claims for 23 patients. 91% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $202 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Salzman for performance year 2024, reported as part of a group. Dr. Salzman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Salzman. Dr. Salzman's most frequent co-author is Fuad Salim Freiha, MD.

CMS Open Payments shows 10 general payments to Dr. Salzman from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $85.

Dmand AI lists 1 award for Dr. Salzman, most recently Regional Top Doctor in 2014.

Dr. Salzman graduated from Boston University School Of Medicine in 1970.

Dr. Salzman is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.